Literature DB >> 20395321

Absorbed 18F-FDG dose to the fetus during early pregnancy.

Paolo Zanotti-Fregonara1, Sébastien Jan, David Taieb, Serge Cammilleri, Régine Trébossen, Elif Hindié, Olivier Mundler.   

Abstract

UNLABELLED: We describe a rare case of a woman who underwent (18)F-FDG PET/CT during early pregnancy (fetus age, 10 wk). The fetal absorbed dose was calculated by taking into account the (18)F-FDG fetal self-dose, photon dose coming from the maternal tissues, and CT dose received by both mother and fetus.
METHODS: The patient (weight, 71 kg) had received 296 MBq of (18)F-FDG. Imaging started at 1 h, with unenhanced CT acquisition, followed by PET acquisition. From the standardized uptake value measured in fetal tissues, we calculated the total number of disintegrations per unit of injected activity. Monte Carlo analysis was then used to derive the fetal (18)F-FDG self-dose, including positrons and self-absorbed photons. Photon dose from maternal tissues and CT dose were added to obtain the final dose.
RESULTS: The maximum standardized uptake value in fetal tissues was 4.5. Monte Carlo simulation showed that the fetal self-dose was 3.0 x 10(-2) mGy/MBq (2.7 x 10(-2) mGy/MBq from positrons and 0.3 x 10(-2) mGy/MBq from photons). The estimated photon dose to the fetus from maternal tissues was 1.04 x 10(-2) mGy/MBq. Accordingly, the specific (18)F-FDG dose to the fetus was about 4.0 x 10(-2) mGy/MBq (11.8 mGy in this patient). The CT scan added a further 10 mGy.
CONCLUSION: The dose to the fetus during early pregnancy can be as high as 4.0 x 10(-2) mGy/MBq of (18)F-FDG. Current dosimetric standards in early pregnancy may need to be revised.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395321     DOI: 10.2967/jnumed.109.071878

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Hodgkin's Disease Staging by FDG PET/CT in a Pregnant Woman.

Authors:  Jérémie Calais; Sébastien Hapdey; Hervé Tilly; Pierre Vera; Mathieu Chastan
Journal:  Nucl Med Mol Imaging       Date:  2014-02-27

2.  Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy.

Authors:  Paolo Zanotti-Fregonara; Thomas M Koroscil; Joseph Mantil; Martin Satter
Journal:  Health Phys       Date:  2012-02       Impact factor: 1.316

3.  Development of computational pregnant female and fetus models and assessment of radiation dose from positron-emitting tracers.

Authors:  Tianwu Xie; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-28       Impact factor: 9.236

4.  The use of PET/CT in pregnancy: A case report of malignant parathyroid carcinoma and a review of the literature.

Authors:  Manpreet Mona Gill; Winnie Sia; Michael Hoskinson; Erin Niven; Rshmi Khurana
Journal:  Obstet Med       Date:  2017-10-09

5.  Estimation of kidneys and urinary bladder doses based on the region of interest in 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography examination: a preliminary study.

Authors:  Farida Aimi Mustapha; Farahnaz Ahmad Anwar Bashah; Ihsan M Yassin; Ahmad Saad Fathinul Fikri; Abdul Jalil Nordin; Hairil Rashmizal Abdul Razak
Journal:  Quant Imaging Med Surg       Date:  2017-06

6.  Hodgkin lymphoma in pregnancy.

Authors:  Veronika Bachanova; Joseph M Connors
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

7.  European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Rodney J Hicks; Elif Hindié; Benjamin A Guillet; Anca Avram; Pietro Ghedini; Henri J Timmers; Aaron T Scott; Saeed Elojeimy; Domenico Rubello; Irène J Virgolini; Stefano Fanti; Sona Balogova; Neeta Pandit-Taskar; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-29       Impact factor: 9.236

Review 8.  Hodgkin lymphoma in the elderly, pregnant, and HIV-infected.

Authors:  Veronika Bachanova; Joseph M Connors
Journal:  Semin Hematol       Date:  2016-05-17       Impact factor: 3.851

Review 9.  Management of Hematologic Malignancies: Special Considerations in Pregnant Women.

Authors:  Odelia Amit; Merav Barzilai; Irit Avivi
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

Review 10.  Therapeutic management of epithelial ovarian cancer during pregnancy.

Authors:  L Minig; L Otaño; I Diaz-Padilla; R Alvarez Gallego; M G Patrono; J Valero de Bernabé
Journal:  Clin Transl Oncol       Date:  2012-11-21       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.